Targeted pill trial aims to wipe out early bladder tumors

NCT ID NCT06995677

Recruiting now Disease control Sponsor: Tyra Biosciences, Inc Source: ClinicalTrials.gov ↗

Summary

This study is testing an oral medication called TYRA-300 for adults with early-stage, non-muscle-invasive bladder cancer that has a specific genetic change (FGFR3). The goal is to see if the pill can completely eliminate visible tumors left in the bladder after a biopsy. Researchers will also monitor side effects to understand the treatment's safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Arkansas Urology
RECRUITING

Little Rock, Arkansas, 72211, United States
Associate Urologist of North Carolina
RECRUITING

Raleigh, North Carolina, 27612, United States
Associated Urological Specialists
RECRUITING

Chicago Ridge, Illinois, 60415, United States
Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara
RECRUITING

Pisa, 56126, Italy
Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States
Carolina Urologic Research Center
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Centro Médico Teknon
RECRUITING

Barcelona, Spain, 08003, Spain
Duly Health and Care
RECRUITING

Lisle, Illinois, 60532, United States
Epworth Freemasons-Victoria Parade
RECRUITING

Richmond, Victoria, 3121, Australia
First Urology
RECRUITING

Jeffersonville, Indiana, 47130, United States
Genesis Research
RECRUITING

San Diego, California, 92123, United States
Hospital Clínico San Carlos
RECRUITING

Madrid, Spain, 28040, Spain
Hospital Universitario 12 de Oc
RECRUITING

Madrid, Spain, 28041, Spain
Hospital Universitario Marqués de Valdecilla
RECRUITING

Santander, 39008, Spain
Hospital Universitario Ramón y Cajal
RECRUITING

Madrid, 28034, Spain
Istituti Fisioterapici Ospitalieri (IFO)
RECRUITING

Rome, Italy, Italy
Keystone Urology Specialists
RECRUITING

Lancaster, Pennsylvania, 17604, United States
Lowcounty Urology Clinics, P.A.
RECRUITING

North Charleston, South Carolina, 29406, United States
MD Anderson Cancer Center - Madrid
RECRUITING

Madrid, 28003, Spain
Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers
RECRUITING

New York, New York, 10065, United States
MidLantic Urology
RECRUITING

Bala-Cynwyd, Pennsylvania, 19004, United States
Oregon Urology Institute
RECRUITING

Springfield, Ohio, 97477, United States
The Bronx Veterans Medical Research Foundation, Inc.
RECRUITING

The Bronx, New York, 10468, United States
Tri Valley Urology - Murrieta
RECRUITING

Murrieta, California, 92562, United States
University of Kansas Medical Center (KUMC)
RECRUITING

Kansas City, Kansas, 66160, United States
Urology Associates PC
RECRUITING

Nashville, Tennessee, 37209, United States
Urology Centers of Alabama
RECRUITING

Homewood, Alabama, 35209, United States
Urology San Antonio
RECRUITING

San Antonio, Texas, 78229, United States

Conditions

Explore the condition pages connected to this study.

FGFR GENE ALTERATIONS FGFR GENE AMPLIFICATION FGFR3 GENE ALTERATION FGFR3 GENE FUSIONS FGFR3 GENE MUTATION LOW-GRADE NMIBC